Begoña Mellado

Publicaciones destacadas

• Safety and efficacy of avelumab plus carboplatin in patients with metastatic castration-resistant prostate cancer in an open-label Phase Ib study

  Autores:

  Rodriguez-Vida, Alejo; Maroto, Pablo; Font, Albert; Martin, Cristina; Mellado, Begona;

  (...)

  Taus, Alvaro; Martinez-Garcia, Maria; Juanpere, Nuria; Juan, Oscar; Bellmunt, Joaquim.

  Ver listado completo de autores

  Referencia: BRITISH JOURNAL OF CANCER 2023.

• Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma.

  Autores:

  Yohann Loriot; Nobuaki Matsubara; Se Hoon Park; Robert Huddart; Earle F. Burgess;

  (...)

  Sydney Akapame; Kris Deprince; Sutapa Mukhopadhyay; Nicole L. Stone; Arlene O. Siefker‐Radtke.

  Ver listado completo de autores

  Referencia: NEW ENGLAND JOURNAL OF MEDICINE 2023.

• Rucaparib or Physician's Choice in Metastatic Prostate Cancer.

  Autores:

  Karim Fizazi; Josep M. Piulats; M. Neil Reaume; Peter Ostler; Ray McDermott;

  (...)

  Catherine Liston‐Heyes; Simon P. Watkins; Simon Chowdhury; Charles J. Ryan; Alan H. Bryce.

  Ver listado completo de autores

  Referencia: NEW ENGLAND JOURNAL OF MEDICINE 2023.

• Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial.

  Autores:

  Arlene O. Siefker‐Radtke; Nobuaki Matsubara; S.H. Park; Robert Huddart; Earle F. Burgess;

  (...)

  Gurjyot K. Doshi; Mark T. Fleming; Joseph Maly; Mamta Parikh; David Waterhouse.

  Ver listado completo de autores

  Referencia: ANNALS OF ONCOLOGY 2023.

• Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer

  Autores:

  Kim N.; Dana E. Rathkopf; Matthew R. Smith; Eleni Efstathiou; Gerhardt Attard;

  (...)

  Neal D. Shore; Paul Sieber; Matthew R. Smith; Andrew Trainer; Ronald Tutrone.

  Ver listado completo de autores

  Referencia: J Clin Oncol . 2023.

• A phase II randomised trial of abiraterone acetate plus prednisone in combination with docetaxel or docetaxel plus prednisone after disease progression to abiraterone acetate plus prednisone in patients with metastatic castration-resistant prostate cancer: The ABIDO-SOGUG trial

  Autores:

  Climent, MA; Font, A; Durán, I; Puente, J; Méndez-Vidal, MJ;

  (...)

  Lázaro-Quintela, M; Cassinello-Espinosa, J; Pérez-Valderrama, B; Garcias, C; Castellano, D.

  Ver listado completo de autores

  Referencia: EUROPEAN JOURNAL OF CANCER 2022.

• Final Overall Survival and Molecular Analysis in IMmotion151, a Phase 3 Trial Comparing Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma

  Autores:

  Motzer, Robert J; Powles, Thomas; Atkins, Michael B; Escudier, Bernard; McDermott, David F;

  (...)

  Craine, Veronica; Huseni, Mahrukh; Flinn, Nick; Dubey, Sarita; Rini, Brian, I.

  Ver listado completo de autores

  Referencia: JAMA Oncology 2022.

• Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial

  Autores:

  Powles, Thomas; Yuen, Kobe C; Gillessen, Silke; Kadel, Edward E; Rathkopf, Dana;

  (...)

  Rasuo, Grozdana; Datye, Asim; Mariathasan, Sanjeev; Williams, Patrick; Sweeney, Christopher J.

  Ver listado completo de autores

  Referencia: NATURE MEDICINE 2022.

• Glutamine and cholesterol plasma levels and clinical outcomes of patients with metastatic castration-resistant prostate cancer treated with taxanes

  Autores:

  Marin-Aguilera, Mercedes; Pereira, Maria V; Jimenez, Natalia; Reig, Oscar; Cuartero, Anna;

  Victoria, Ivan; Aversa, Caterina; Ferrer-Mileo, Laura; Prat, Aleix; Mellado, Begona.

  Referencia: Cancers 2021.

• Taxane-induced Attenuation of the CXCR2/BCL-2 Axis Sensitizes Prostate Cancer to Platinum-based Treatment

  Autores:

  Ruiz de Porras, Vicenc; Wang, Xieng C; Palomero, Luis; Marin-Aguilera, Mercedes; Sole-Blanch, Carme;

  (...)

  Beltran, Himisha; Mellado, Begona; Martinez-Balibrea, Eva; Font, Albert; Aytes, Alvaro.

  Ver listado completo de autores

  Referencia: EUROPEAN UROLOGY 2021.